<DOC>
	<DOCNO>NCT00330486</DOCNO>
	<brief_summary>The purpose study determine whether acamprosate ( Campral ) safe effective treat alcohol dependence individual bipolar disorder . All subject study must currently stabilize mood-stabilizing medication . Half subject receive acamprosate addition mood-stabilizing medication ; control subject maintain mood-stabilizing medication alone . Measures alcohol use well mood stability obtain weekly throughout active phase study .</brief_summary>
	<brief_title>Open Label Trial Acamprosate Bipolar Alcoholics</brief_title>
	<detailed_description />
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Acamprosate</mesh_term>
	<criteria>Adults age 1865 Meet DSMIV criterion current ( past 90 day ) alcohol dependence Meet DSMIV criterion bipolar I bipolar II disorder Currently mood stabilize medication regimen , include use lithium , valproic acid , lamotrigine , and/or antipsychotic agent FDA approve treat bipolar disorder without dosage adjustment past month Must able remain free alcohol least 3 day prior medication initiation Subjects must able adequately provide informed consent function intellectual level sufficient allow accurate completion assessment instrument Subjects must consent random assignment willing commit medication treatment followup assessment Individuals primary psychiatric disorder bipolar disorder Individuals uncontrolled neurologic condition could confound result study Individuals uncontrolled medical condition may adversely affect conduct trial jeopardize subject 's safety Participants creatine clearance less equal half normal value indicate chem . 7 result conduct screening visit . Concomitant use psychotropic medication allow per protocol Women childbearing potential pregnant , lactate refuse use adequate form birth control Current suicidal homicidal risk Baseline score &gt; 35 Montgomery Asberg Depression Rating Scale and/or &gt; 25 Young Mania Rating Scale</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Acamprosate</keyword>
	<keyword>Addiction</keyword>
	<keyword>Alcoholism</keyword>
	<keyword>Alcohol dependence</keyword>
	<keyword>Bipolar disorder</keyword>
	<keyword>Depression</keyword>
	<keyword>Impulsivity</keyword>
	<keyword>Mania</keyword>
	<keyword>Substance abuse</keyword>
</DOC>